 |
answer text |
<p>Intellectual Property rights have been critical in underpinning innovators’ confidence
to form over 300 partnerships - an unprecedented number - which have made real, positive
impacts on vaccine delivery; examples include AstraZeneca and the Serum Institute
of India, and Pfizer-BioNTech and BIOVAC in South Africa. These examples show what
is possible when the right partners work together and share technology.</p><p> </p><p>While
we must continue to ensure vaccine production needs are met globally, the WHO news
release of 7 October made it clear that, “With global vaccine production now at nearly
1.5 billion doses per month, there is sufficient vaccine from a supply perspective
to achieve global vaccination targets”. We must therefore also focus on issues of
distribution and delivery to successfully vaccinate the globe.</p>
|
 |
